| |
| |
|
| Insider
Information: |
Brege Laura |
| Relationship: |
Director |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
99,672 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$703,461 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
99,672 |
|
|
| Total
Value |
$703,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 46.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP, Corporate Affairs |
2011-10-14 |
39,670 |
2007-03-30 |
0 |
Premium* |
|
|
Delcath Systems Inc |
DCTH |
Director |
2014-07-07 |
11,678 |
2013-06-05 |
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
Director |
2023-06-12 |
13,502 |
2013-09-10 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2023-06-14 |
11,322 |
2014-05-09 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2016-06-17 |
0 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
Director |
2018-07-27 |
13,500 |
2016-06-24 |
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
Director |
2019-09-10 |
10,000 |
2019-09-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
98 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,552 |
18,002 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,775 |
11,322 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2013-10-10 |
4 |
OE |
$1.30 |
$13,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2014-01-15 |
4 |
OE |
$1.36 |
$13,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2014-09-15 |
4 |
OE |
$1.75 |
$17,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2015-02-11 |
4 |
OE |
$1.75 |
$17,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2020-01-07 |
4 |
OE |
$1.75 |
$17,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2019-01-09 |
4 |
OE |
$2.16 |
$21,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-06-05 |
4 |
AS |
$38.74 |
$23,244 |
D/D |
(600) |
9,547 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2014-04-04 |
4 |
OE |
$1.75 |
$24,999 |
D/D |
14,285 |
14,285 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP and Chief Business Officer |
• – – |
2008-03-31 |
4 |
D |
$29.03 |
$34,604 |
D/D |
(1,192) |
11,221 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2016-06-06 |
4 |
AS |
$46.95 |
$46,950 |
D/D |
(1,000) |
1,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2013-09-10 |
4 |
OE |
$1.30 |
$59,999 |
D/D |
46,153 |
46,153 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2013-12-10 |
4 |
OE |
$1.36 |
$59,999 |
D/D |
44,117 |
44,117 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP and Chief Business Officer |
• – – |
2008-04-02 |
4 |
AS |
$30.87 |
$66,124 |
D/D |
(2,142) |
15,079 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP and Chief Business Officer |
• – – |
2010-03-31 |
4 |
AS |
$30.15 |
$100,490 |
D/D |
(3,333) |
22,460 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2020-06-05 |
4 |
S |
$48.70 |
$102,270 |
D/D |
(2,100) |
6,661 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2023-06-12 |
4 |
AS |
$24.87 |
$111,906 |
D/D |
(4,500) |
13,502 |
0 |
% |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Director |
– • – |
2019-09-10 |
4 |
B |
$11.22 |
$112,200 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-05-09 |
4 |
OE |
$10.81 |
$117,610 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP and Chief Business Officer |
• – – |
2010-04-01 |
4 |
AS |
$30.10 |
$130,453 |
D/D |
(4,334) |
18,126 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-07-02 |
4 |
D |
$18.00 |
$131,058 |
D/D |
(7,281) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP and Chief Business Officer |
• – – |
2009-04-01 |
4 |
AS |
$27.90 |
$148,791 |
D/D |
(5,333) |
17,241 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Affairs |
• – – |
2011-04-26 |
4 |
OE |
$15.44 |
$154,400 |
D/D |
10,000 |
49,427 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Affairs |
• – – |
2011-07-14 |
4 |
OE |
$15.44 |
$154,400 |
D/D |
10,000 |
49,427 |
0 |
- |
|
98 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
